1. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014; 70:205.e1–205.e16.
2. Ahn CS, ALSayyah A, Sangüeza OP. Mycosis fungoides: an updated review of clinicopathologic variants. Am J Dermatopathol. 2014; 36:933–948.
3. Ko JW, Seong JY, Suh KS, Kim ST. Pityriasis lichenoides-like mycosis fungoides in children. Br J Dermatol. 2000; 142:347–352.
Article
4. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007; 110:1713–1722.
Article
5. Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005; 53:1053–1063.
Article
6. de Unamuno Bustos B, Ferriols AP, Sánchez RB, Rabasco AG, Vela CG, Piris MA, et al. Adult pityriasis lichenoides-like mycosis fungoides: a clinical variant of mycosis fungoides. Int J Dermatol. 2014; 53:1331–1338.
Article
7. Vonderheid EC, Kadin ME. Papular mycosis fungoides: a variant of mycosis fungoides or lymphomatoid papulosis? J Am Acad Dermatol. 2006; 55:177–180.
Article
8. Cerroni L. Skin lymphoma: the illustrated guide. 4th ed. Hoboken: Wiley-Blackwell;2014.
9. Magro C, Crowson AN, Kovatich A, Burns F. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol. 2002; 33:788–795.
Article
10. Rivers JK, Samman PD, Spittle MF, Smith NP. Pityriasis lichenoides-like lesions associated with poikiloderma: a precursor of mycosis fungoides. Br J Dermatol. 1986; 115:17.
11. Dereure O, Levi E, Kadin ME. T-Cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000; 136:1483–1486.
12. Massone C, Kodama K, Kerl H, Cerroni L. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol. 2005; 29:550–560.
13. Suh KS, Kang JS, Baek JW, Kim TK, Lee JW, Jeon YS, et al. Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases. Ann Dermatol. 2010; 22:1–8.
Article
14. Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Austin LM, Coven TR, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999; 189:711–718.
Article
15. Jang MS, Baek JW, Park JB, Kang DY, Kang JS, Suh KS, et al. Narrowband ultraviolet B phototherapy of early stage mycosis fungoides in Korean patients. Ann Dermatol. 2011; 23:474–480.
Article
16. Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Investig Dermatol Symp Proc. 1999; 4:70–72.
Article
17. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014; 70:223.e1–223.e17.
18. Prince HM, Whittaker S, Hoppe RT. How I treat mycosis fungoides and Sézary syndrome. Blood. 2009; 114:4337–4353.
Article
19. Wang SH, Hsiao CH, Hsiao PF, Chu CY. Adult pityriasis lichenoides-like mycosis fungoides with high density of CD8-positive T-lymphocytic infiltration. J Eur Acad Dermatol Venereol. 2007; 21:401–402.
Article